Immuneering Presents Atebimetinib Pancreatic Cancer Data at AACR
NEW YORK — September 28, 2026 Immuneering Corporation presented new data at the 2026 AACR Conference on Pancreatic Cancer...
AACR 2026
Advertisement
SELLAS Presents SLS009 Preclinical Data in Pancreatic Cancer
NEW YORK — September 25, 2026 SELLAS Life Sciences Group presented new preclinical data for SLS009 (tambiciclib) in patient-derived...
SELLAS Presents SLS009 Preclinical Data in Pancreatic Cancer at AACR 2026
New York, September 2, 2026 SELLAS Life Sciences Group, Inc. announced that three abstracts evaluating SLS009 (tambiciclib), a potent...
Vesalio’s NATURE Trial Selected for ESC 2026 Late-Breaking Session
DALLAS, Texas, July 21, 2026 Vesalio has announced that its NATURE randomized clinical trial evaluating the enVast™ Coronary Thrombectomy...
Verismo Therapeutics Unveils New SynKIR-310 AACR Data
PHILADELPHIA, April 21, 2026 Verismo Therapeutics has unveiled compelling preclinical and early clinical findings for SynKIR™-310, its investigational multi-chain...
Advertisements
VERAXA Achieves Key Regulatory Milestone for BiTAC-TCE
ZURICH, Switzerland, July 20, 2026 VERAXA Biotech AG (NASDAQ: VRXA) announced that it has received Scientific Advice from Germany’s...
RedHill’s Opaganib Gains FDA Rare Pediatric Disease Status
RALEIGH, North Carolina, USA & TEL AVIV, Israel – June 9, 2026 RedHill Biopharma has received a significant regulatory...
MiNK Advances iNKT Cell Therapy Into Phase 2 Validation
NEW YORK, May 15, 2026 MiNK Therapeutics, Inc. reported first quarter 2026 financial results while highlighting major clinical and...
KUBTEC Launches XCELL TomoRad IGRT Research System
STRATFORD, Conn., May 8, 2026 KUBTEC Scientific has launched the XCELL® TomoRad™ x-ray irradiator, a next-generation image-guided radiotherapy (IGRT)...
Nuvation Bio Expands IBTROZI FDA Lung Cancer Filing
NEW YORK, May 6, 2026 Nuvation Bio Inc., a global oncology-focused biopharmaceutical company, has announced that the U.S. Food...
Advertisement
